ClinicalTrials.Veeva

Menu

Cerclage for Short Cervix in Twins

S

Saint Louis University (SLU)

Status

Terminated

Conditions

Short Cervix, Twins

Treatments

Other: Expectant management
Procedure: Cerclage

Study type

Interventional

Funder types

Other

Identifiers

NCT02912390
Cerclage in Twins (Other Identifier)
27073a

Details and patient eligibility

About

Through cervical length measurement in uncomplicated twin gestations, women with cervical length ≤ 25 mm will be approached for randomization to cerclage placement or expectant management with activity restriction and treatment of preterm labor

Full description

Pregnant women with twin gestations are screened for short cervix with transvaginal cervical length measurements as part of routine care at St. Mary's Health Center (SMHC) and Saint Louis University's (SLUCare) Physician Group. (Transvaginal cervical length measurement every 2 weeks from 16weeks/0days-23weeks/6days weeks, per hospital practice) Women pregnant with twin gestations at SMHC who meet study criteria will undergo transvaginal length screening between 16 and 24 weeks gestation. Those women with transvaginal cervical length measurements at or below 25 mm will be approached for study participation.

If a patient agrees to participate in the trial, they will be randomized in 1:1 fashion to cerclage vs. expectant management.

Participants found to have a vaginal infection by cultures performed at randomization will be treated with appropriate antibiotics per usual institutional practices

Cerclage arm:

  • Macdonald cerclage placed in standard fashion: mersilene suture preferred for standardization

Expectant management arm:

  • Patient is placed on activity restrictions: no heavy lifting, frequent reclining, and pelvic rest.

If a participant does not consent to participate in the trial, permission to collect their outcome information in an observational manner will be requested.

The neonatal medical record will be reviewed for outcome data on twins, weights, complications, neonatal intensive care unit (NICU) stay, to 28 day after discharge.

Enrollment

9 patients

Sex

Female

Ages

14 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • at least 14 years of age, but less than 55 yrs of age
  • must be able to read and write English
  • must be able to give informed consent.
  • Twin pregnancy

Exclusion criteria

  • Women with a serious physical or mental illness or condition that would substantially interfere with participation in the study
  • membrane prolapse beyond the external cervical os,
  • major fetal anomaly in either twins will be excluded from randomization.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

9 participants in 2 patient groups

Cerclage
Active Comparator group
Description:
- Macdonald cerclage placed in standard fashion
Treatment:
Procedure: Cerclage
Expectant management
Active Comparator group
Description:
- Patient is placed on activity restrictions
Treatment:
Other: Expectant management

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems